reduced in compare with their counterpart samples in group II, which shows the effect of gabapentin mainly in chronic phase of formalin test as an acute pain. Consequently
revealed that some compounds of Ru(II)were capable of change cell cycle distribution since the percentage of cells in the G1 phases increased. In addition, treatment with these compounds
phase separation study, droplet size analysis, zeta potential, turbidity, viscosity and in vitro release studies. In vitro release studies were carried by using USP dissolution apparatus XXIV-Type II. Antiinflammatory
exposure. Thus, the results imply that AHH exposure of 24 h cause alterations in phase II drug metabolism, CYP2C9 expression, PK and liver histology as well as liver function
locations. Clinical trials involving new drugs are commonly classified into four phases as Phase I, II, III, IV. The drug-development process will normally proceed through all four phases over
following points for its ability to minimize drug approval time: i) Abbreviating the phase which accounts for the most time expend during drug development and approval i.e clinical trials ... providing early and regular…
with a C18 (4.6 mm x 250 mm x 5m) column as stationary phase for simultaneous separation of tenofovir disoproxil fumarate and efavirenz. The separation was achieved ... medium was preceded by establishment of the sink…
reactivity and improved clinical and pathological disease manifestations. Our preliminary results of a phase I/II open clinical trial to evaluate the feasibility and safety of intrathecal and intravenous administration
fourth (analysis of massive number of observation by their results of multicenter trials) phases of clinical trials are absent. As the result in short period of time developed and implemented ... Wharton jelly to…
population. The compound is well-tolerated in phase I clinical trials, and is under phase II development for the treatment of several inflammatory diseases
peptides are promiscuous and able to bind to both HLA class I and class II molecules. The adjuvants, Montanide ISA-51 and Imiquimod, induce efficient innate immune responses strongly activating ... lymphocytes. Safety…
graft vs. host disease (GVHD) and in treatment of ulcerative colitis in an ongoing Phase II study with Pfizer. Athersys and collaborators have performed focused pre-clinical animal studies ... More recently, we filed…
suggested that the modified molecule C9 has a higher binding affinity for carbonic anhydrase II which promotes higher bioavailability. DCA inhibits the mitochondrial gate keeping enzyme pyruvate dehydrogenase kinase…
RNAs (siRNAs) in a cell cycle-dependent manner: at S phase, heterochromatin is briefly transcribed by RNA Polymerase II, and the transcripts are subsequently processed into siRNAs. The small RNAs
extraction medium. The complexes were subsequently entrapped in surfactant micelles. The surfactant-rich phases were diluted with suitable solvent and the lead and cadmium contents were measured spectrophotometerically…
have started a double-blind, placebo-controlled, randomized multicenter clinical trial (EPO-AMI-II) to clarify the safety and efficacy of a low-dose of EPO on the improvement ... acute and chronic phase (6 months)…
bilaterally blind. Glutathione S-transferases (GST) are a group of drug-metabolizing enzymes of phase-II that act in the detoxification of xenobiotics and inactivate end-products formed as secondary ... bilaterally…
between the level of certain isoforms belonging to histone deacetylase (HDAC) classes I and II and aggressiveness and poor prognosis of some malignancies. Diverse structural classes of HDAC inhibitors (HDACIs ... phase…
complimentary tools to characterise a fractured-rock aquifer contaminated with light non-aqueous phase liquids (LNAPLs). The aquifer is located in a Karoo town of South Africa. Field investigations were ... reducing…
potential strategy for lung cancer chemoprevention uses the property of these agents to activate phase II carcinogen detoxification enzymes thus modulating the metabolism of tobacco and other environmental carcinogens…
likely associated with Terrorist-CBRN (T-CBRN) derived from our interpretation of the literature; Phase II involved constructing a ‘Random Nations Matrix’ from 74 countries or locations of the world
been one of the effective immunotherapies for eradicating advanced tumor burdens. We reported a phase II trial where patients with stage IV renal cell cancer (RCC) were vaccinated with irradiated
Epratuzamab, which targets CD 22 is in Phase III trials (EMBODY) with impressive Phase II data. Subcutaneous LY2127399, also a B-cell depletor blocks both soluble and membrane bound ... factor (BAFF). Two MAb against…
Epratuzamab, which targets CD 22 is in Phase III trials (EMBODY) with impressive Phase II data. Subcutaneous LY2127399, also a B-cell depletor blocks both soluble and membrane bound ... factor (BAFF). Two MAb against…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.